Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Banca Mediolanum SpA (BMED)
Track the Banca Mediolanum share price today and view real-time BMED share price data, including charts, technicals, and key financials. View the BMED premarket stock price ahead of the market session or assess the after hours quote. Explore BMED stock price movements, trading volume, and market activity across the BIT exchange.
What Is the Banca Mediolanum Stock Price Today?
The Banca Mediolanum stock price today is 24.190.
What Is the Stock Symbol for Banca Mediolanum?
The stock symbol for Banca Mediolanum is ""BMED.""
What Stock Exchange Does Banca Mediolanum Trade On?
Banca Mediolanum is listed and trades on the Milan stock exchange.
Is Banca Mediolanum a Good Stock to Buy?
Determining whether Banca Mediolanum or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BMED quote. (ISIN: IT0004776628)
What Is the Banca Mediolanum Stock Price Today?
The Banca Mediolanum stock price today is 24.190.
What Is the Stock Symbol for Banca Mediolanum?
The stock symbol for Banca Mediolanum is ""BMED.""
What Stock Exchange Does Banca Mediolanum Trade On?
Banca Mediolanum is listed and trades on the Milan stock exchange.
Is Banca Mediolanum a Good Stock to Buy?
Determining whether Banca Mediolanum or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BMED quote. (ISIN: IT0004776628)
24.190
+0.100(+0.42%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.060
24.540
52 wk Range
15.990
24.540
Trading near 52-week High
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.06024.540
52 wk Range
15.99024.540
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BMED Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
24.810
Upside
+2.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Mediolanum receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Mediolanum receives Investment Bank Analyst Rating Update- Investing.com
Pro
Mediolanum receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 24.810
(+2.56% Upside)
Banca Mediolanum SpA Earnings Call Summary for Q3/2025
- Banca Mediolanum reported Q3 2025 net income of €726 million (+8% YoY), with stock rising 2.29% to €17.45 following the announcement despite a 5% decline in net interest income.
- Net commission income surged 11% to €967 million, offsetting interest income decline and helping drive a 5% increase in both contribution margin (€1.56B) and operating margin (€891M).
- The bank launched a new Intelligent Investment Strategy and reported strong managed asset net inflows, with CEO Massimo Doris expressing confidence in the company's model and strategy.
- Management forecasts double-digit net interest income growth for 2026, targeting €8-8.5B in managed asset inflows, maintaining cost-to-income ratio below 40%, and planning €0.60/share dividend.
- Analysts raised questions about performance fees (estimated at €150M), stable management fee margins, and the company's investment in Spanish operations, which is expected to improve profitability.
Last Updated: 07/11/2025, 05:22 am
Read Full TranscriptEarnings
Latest Release
30/07/2026
EPS / Forecast
0.38 / 0.34
Revenue / Forecast
581M / --
Compare BMED to Peers and Sector
Metrics to compare | BMED | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipBMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.5x | 12.9x | 10.1x | |
PEG Ratio | 0.90 | 0.67 | 0.03 | |
Price/Book | 3.7x | 1.8x | 1.0x | |
Price / LTM Sales | 7.1x | 4.3x | 3.0x | |
Upside (Analyst Target) | 2.3% | 4.4% | 12.9% | |
Fair Value Upside | Unlock | −6.1% | 2.0% | Unlock |
Banca Mediolanum S.p.A. engages in the provision of various banking products and services in Italy. It offers current accounts; deposits products; and mortgage and personal loans. The company also provides credit cards, debit cards, and prepaid cards; investment products, such as mutual funds, unit linked policies, investment strategies, trading services, asset management services, social security, and bond issues and certificates; and insurance policies, including health and personal, life, serious illness, and autonomy protection, as well as protection assistance, and home and family protection. In addition, it offers SelfyCare Pet for reimbursement of veterinary expenses; SelfyCare Travel for assistance and coverage for risks arising during trips; and SelfyCare LifeProject for a specific life project. Banca Mediolanum S.p.A. founded in 1982 and is headquartered in Basiglio, Italy.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Banca Mediolanum (BMED) Stock Price Today?
The Banca Mediolanum stock price today is 24.190 EUR.
What Stock Exchange Does Banca Mediolanum Trade On?
Banca Mediolanum is listed and trades on the Milan Stock Exchange.
What Is the Stock Symbol for Banca Mediolanum?
The stock symbol for Banca Mediolanum is "BMED."
Does Banca Mediolanum Pay Dividends? What’s The Current Dividend Yield?
The Banca Mediolanum dividend yield is 5.22%.
What Is the Banca Mediolanum Market Cap?
As of today, Banca Mediolanum market cap is 17.950B EUR.
When Is the Next Banca Mediolanum Earnings Date?
Banca Mediolanum will release its next earnings report on 10/11/2026.
From a Technical Analysis Perspective, Is BMED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Banca Mediolanum Stock Split?
Banca Mediolanum has split 0 times.
How Many Employees Does Banca Mediolanum Have?
Banca Mediolanum has 4138 employees.
What is the current trading status of Banca Mediolanum (BMED)?
As of 06/08/2026, Banca Mediolanum (BMED) is trading at a price of 24.190 EUR, with a previous close of 24.090 EUR. The stock has fluctuated within a day range of 24.060 EUR to 24.540 EUR, while its 52-week range spans from 15.990 EUR to 24.540 EUR.
What Is Banca Mediolanum (BMED) Price Target According to Analysts?
The average 12-month price target for Banca Mediolanum is 24.810 EUR, with a high estimate of 27 EUR and a low estimate of 23.4 EUR. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +2.56% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.